Makoto Yasuda

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

Noriyuki Katsumata, Makoto Yasuda, Fumiaki Takahashi et al. · The Lancet · 2009 · 731 citations

Advanced Ovarian Cancer, Medicine, Metronomic Therapy +9

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial

Noriyuki Katsumata, Makoto Yasuda, Seiji Isonishi et al. · The Lancet Oncology · 2013 · 468 citations

Gastrointestinal Oncology, Conventional Paclitaxel, Medicine +9

Direct Carbon–Carbon Bond Formation from Alcohols and Active Methylenes, Alkoxyketones, or Indoles Catalyzed by Indium Trichloride

Makoto Yasuda, Toshio Somyo, Akio Baba · Angewandte Chemie International Edition · 2005 · 304 citations

Chemical Engineering, Cross-coupling Reaction, Engineering +12

A critical role of IL-33 in experimental allergic rhinitis

Yoko Haenuki, Kazufumi Matsushita, Shizue Futatsugi‐Yumikura et al. · Journal of Allergy and Clinical Immunology · 2012 · 225 citations

Experimental Allergic Rhinitis, Allergy, Allergy Medicine +5

Direct Reduction of Alcohols:  Highly Chemoselective Reducing System for Secondary or Tertiary Alcohols Using Chlorodiphenylsilane with a Catalytic Amount of Indium Trichloride

Makoto Yasuda, Yoshiyuki Onishi, Masako Ueba et al. · The Journal of Organic Chemistry · 2001 · 197 citations

Chemical Engineering, Hydride Source, Engineering +14